Skip to main content

X4 Pharmaceuticals, Inc

XFOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001501697

In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 3 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in X4 Pharmaceuticals, Inc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
98
+1 vs. Q2 2024
Shares held
100.6M
+9.73M (+10.7%) vs. Q2 2024
Total value
$67.3M
+$14.6M (+27.7%) vs. Q2 2024
New holders
12
35 more added
Sold out
11
18 more reduced

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting XFOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 98 institutions
Q1 2021: 61 institutionsQ2 2021: 63 institutionsQ3 2021: 52 institutionsQ4 2021: 52 institutionsQ1 2022: 56 institutionsQ2 2022: 51 institutionsQ3 2022: 59 institutionsQ4 2022: 54 institutionsQ1 2023: 59 institutionsQ2 2023: 96 institutionsQ3 2023: 91 institutionsQ4 2023: 93 institutionsQ1 2024: 98 institutionsQ2 2024: 99 institutionsQ3 2024: 98 institutionsQ4 2024: 90 institutionsQ1 2025: 94 institutionsQ2 2025: 52 institutionsQ3 2025: 42 institutionsQ4 2025: 79 institutionsQ1 2026: 84 institutionsQ2 2026: 89 institutions
Value heldQ3 2024: $67.3M
Q1 2021: $138.7MQ2 2021: $107.8MQ3 2021: $85.7MQ4 2021: $40.2MQ1 2022: $28.6MQ2 2022: $15.5MQ3 2022: $66.9MQ4 2022: $60.2MQ1 2023: $53.6MQ2 2023: $219.1MQ3 2023: $122.6MQ4 2023: $81.2MQ1 2024: $143.2MQ2 2024: $58.9MQ3 2024: $67.3MQ4 2024: $73.2MQ1 2025: $23.3MQ2 2025: $5.33MQ3 2025: $55.3MQ4 2025: $357.7MQ1 2026: $388.1MQ2 2026: $463.0M
Institutions holding XFOR and their total value by quarter
QuarterHoldersValue
Q2 202689$463.0M
Q1 202684$388.1M
Q4 202579$357.7M
Q3 202542$55.3M
Q2 202552$5.33M
Q1 202594$23.3M
Q4 202490$73.2M
Q3 202498$67.3M
Q2 202499$58.9M
Q1 202498$143.2M
Q4 202393$81.2M
Q3 202391$122.6M
Q2 202396$219.1M
Q1 202359$53.6M
Q4 202254$60.2M
Q3 202259$66.9M
Q2 202251$15.5M
Q1 202256$28.6M
Q4 202152$40.2M
Q3 202152$85.7M
Q2 202163$107.8M
Q1 202161$138.7M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding X4 Pharmaceuticals, Inc; share changes are against Q2 2024.

Institutions holding XFOR in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Hudson Bay Capital Management LP0$00.00%−227,246−100.0%Sold out
Virtu Financial LLC0$00.00%−50,537−100.0%Sold out
Holistic Planning, LLC0$00.00%−13,800−100.0%Sold out
Resources Investment Advisors, LLC.0$00.00%−21,500−100.0%Sold out
Allred Capital Management, LLC0$00.00%−12,800−100.0%Sold out
Jump Financial, LLC0$00.00%−10,362−100.0%Sold out
Citadel Advisors LLC0$00.00%−8,413−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−1,901−100.0%Sold out
Headlands Technologies LLC0$00.00%−16−100.0%Sold out
BlackRock Inc.––––Not filed
ICA Group Wealth Management, LLC––––Not filed